Intrathecal Drug Delivery for Chronic Pain
Selecting Patients and Optimizing Long-Term Outcomes
Meeting Slides
Guidelines
Polyanalgesic Consensus Conference—2012: Recommendations on Trialing for Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel
Deer TR, et al. Neuromodulation. 2012;15(5):420-435.
Polyanalgesic Consensus Conference—2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel
Deer TR, et al. Neuromodulation. 2012;15(5):436-464.
Polyanalgesic Consensus Conference—2012: Recommendations to Reduce Morbidity and Mortality in Intrathecal Drug Delivery in the Treatment of Chronic Pain
Deer TR, et al. Neuromodulation. 2012;15(5):467-482.
Polyanalgesic Consensus Conference—2012: Consensus on Diagnosis, Detection, and Treatment of Catheter-Tip Granulomas (Inflammatory Masses)
Deer TR, et al. Neuromodulation. 2012;15(5):483-495.
Best Practices for Intrathecal Drug Delivery for Pain
Prager J, et al. Neuromodulation. 2014;17(4):354-372.
Suggested Readings
Mortality Associated With Implantation and Management of Intrathecal Opioid Drug Infusion Systems to Treat Noncancer Pain
Coffey RJ, et al. Anesthesiology. 2009;111(4):881-891.
Intrathecal Ziconotide and Opioid Combination Therapy for Noncancer Pain: an Observational Study
Deer TR, et al. Pain Physician. 2009;12(4):E291-E296.
A Predictive Model for Intrathecal Opioid Dose Escalation for Chronic Non-Cancer Pain
Duarte RV, et al. Pain Physician. 2012;15(5):363-369.
Prospective Study of 3-Year Follow-up of Low-Dose Intrathecal Opioids in the Management of Chronic Nonmalignant Pain
Hamza M, et al. Pain Med. 2012;13(10):1304-1313.
Androgen Deficiency in Long-term Intrathecal Opioid Administration
Kim CH, et al. Pain Physician. 2014;17(4):E543-E548.
Practical Considerations and Patient Selection for Intrathecal Drug Delivery in the Management of Chronic Pain
Saulino M, et al. J Pain Res. 2014;7:627-638.
Safety and Efficacy of Intrathecal Ziconotide in the Management of Severe Chronic Pain
Smith HS, Deer TR. Ther Clin Risk Manag. 2009;5(3):521-534.
Long-term Intrathecal Ziconotide for Chronic Pain: an Open-Label Study
Webster LR, et al. J Pain Symptom Manage. 2009;37(3):363-372.
Clinical Accuracy and Safety Using the SynchroMed II Intrathecal Drug Infusion Pump
Wesemann K, et al. Reg Anesth Pain Med. 2014;39(4):341-346.
Programmable Intrathecal Pumps for the Management of Chronic Pain: Recommendations for Improved Efficiency
Wilkes D. J Pain Res. 2014;7:571-577.
Selecting Patients and Optimizing Long-term Outcomes
Relevant Resources
Balancing the Benefits and Risk of Opioid-Based Therapy
Individualized Assessment and Mechanism-Based Multimodal Treatment
Responsible Opioid Prescribing to Achieve Individualized Functional Goals
Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes
Proactive Diagnosis and Targeted Management
Proactive Diagnosis and Targeted Management
Consensus and Controversies for Responsible Opioid Prescribing
The Role of Nurses in Optimizing Long-term Outcomes
Evolving Best-Practice Strategies to Maximize Efficacy and Safety
A Focus on Patients With Opioid-Induced Constipation
Patient Selection, Treatment Initiation, and Ongoing Monitoring
Engaging With Patients About Opioid-Induced Constipation
The PCP’s Role in Timely Recognition and Referral
Debates and Discussions About Therapeutically Targeting Nerve Growth Factor Signaling
Expanding the Conversation on Opioid-Induced Constipation
Translating Guidelines Into Patient Care
New Paths to Chronic Pain Management
Unlocking Novel Paths to Patient Care
Getting on the Fast Track to Identify AxSpA
